Compare ADMA Biologics Inc (ADMA) vs PPG Industries, Inc. (PPG) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs PPG Industries, Inc. — how do they compare? ADMA Biologics Inc trades at $9.22 (market cap $2.13B), while PPG Industries, Inc. trades at $114.26 (market cap $26.80B). The key difference: PPG Industries, Inc. is far larger — about 12.6× ADMA Biologics Inc's market cap, and PPG Industries, Inc. pays a 2.36% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.
| ADMA | PPG | |
|---|---|---|
Market Cap | $2.13B | $26.80B |
Sector | Health | Basic Materials |
52-Week High | $20.38 | $131.56 |
52-Week Low | $7.60 | $94.34 |
Enterprise Value | $2.20B | $32.90B |
Dividend Yield | — | 2.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
PPG Industries (PPG) trades at $120.22, down 4.08% on the day, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings of $1.83 per share, beating estimates, and maintains solid profitability with a net margin of 9.83% and ROE of 21.09%. Recent news highlights innovation in aerospace and marine coatings, including a green chemistry award for SIGMAGLIDE 2390 coating.
The outlook is supported by analyst consensus with a $129.40 price target and 52.63% buy ratings, but risks include volume softness and margin pressure. Earnings growth and sustainability initiatives are key catalysts, though macroeconomic headwinds and competitive pressures remain concerns for sustained shareholder value.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About PPG Industries, Inc.
PPG is a global producer of coatings. The company is the world's largest producer of coatings after the purchase of selected Akzo Nobel assets. PPG's products are sold to a wide variety of end users, including the automotive, aerospace, construction, and industrial markets. The company has a footprint in many regions around the globe, with less than half of sales coming from North America in recent years. PPG is focused on its coatings and specialty products and expansion into emerging regions, as exemplified by the Comex acquisition.
Read more on PPG →
